People stick to their initial drug choices even when new treatments become available. In the March 2024 issue of REStat by Josh Feng, Josh Feng. zurl.co/2bll

Join Felix Poege and I for our AOM paper symposium on "Strategic Patenting, Innovation and Competition in Pharmaceuticals" ft. Josh Feng Jennifer Kao Lucy Xiaolu Wang Stefan Wagner & David Hsu! 8/12 @ 11:30AM; Sheraton Mississippi

Interesting work suggesting drugs in Medicare's protected classes have seen lower rebates over time.

I have a few overdue research updates I will post about in the next week or two. But first, our department HMS HCP is hiring a postdoc to work with me on pharma topics. Posting here: benny.aeaweb.org/joe/listing.ph… Please circulate, and feel free to reach out with any questions!

Research update: we have a new version of our pharma M&A paper! AND, we posted the data we collected on m&a deals. Links below, main takeaways in thread. Paper summary: lucamaini.com/working-papers… Full draft: lucamaini.com/s/feng_hwang_l… Data: lucamaini.com/data

🚨 What happens when the gov't cuts prices on medical technologies? New research (w/ Yunan Ji) finds a 61% price cut led to: 75% drop in innovation (may fully offset savings) 49% fewer new firms 28% more production moved overseas 3x repair/replacement rate 🧵(1/n)

I'm the chair of the prescription drug area this year. Please send in all your pharma papers! The more submissions an area receives, the more we accept. If you need help putting together a session, check the single abstract listing (link at ashecon.org/2025-nashville…) or email me!

1/5 Looking for a clear and gentle intro to shift-share instruments? I'm excited to release today our "practice guide to shift-share instruments" with Kirill Borusyak and Peter Hull, forthcoming at the Journal of Economic Perspectives AEA Journals 👇👇👇👇👇

Great to see our oped on AI and jobs out in Project Syndicate, with Philippe Aghion and Simon Bunel. While many warn that AI will undermine employment and offer only modest productivity gains, empirical studies continue to suggest otherwise👇👇👇 project-syndicate.org/commentary/ai-…

Apply by 6-Feb: NBER Innovation Research Boot Camp, July 11-17 With support from Open Philanthropy: - classes: Pierre Azoulay Kevin A. Bryan Ina Ganguli 🇺🇦 🌻🪷 Ben Jones Chad Jones Kyle Myers me - panel: Matt Clancy dylan matthews 🔸 Caleb Watney - keynotes: Glenn Hubbard & Ronnie Chatterji

Many industries where the government is a major regulator, purchaser, or supplier suffer from severe worker shortages (e.g., healthcare, transportation, education, public safety). A quick thread on our new The Review of Economics and Statistics (REStat) showing how government payment incentives can help: 1/N

Forthcoming in AEJ: Applied Economics: "The Long-Term Impacts of Mixing the Rich and Poor: Evidence from Conscript Dorms" by Elias Einiö. aeaweb.org/articles?id=10…